Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

Παρόμοια τεκμήρια

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  ανά: Caorsi, R, κ.ά.
  Έκδοση: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  ανά: Caorsi, Roberta, κ.ά.
  Έκδοση: (2013)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  ανά: Bibalo, C, κ.ά.
  Έκδοση: (2011)
• Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
  ανά: Toker, Ori, κ.ά.
  Έκδοση: (2010)
• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  ανά: Svetlana Olegovna Salugina, κ.ά.
  Έκδοση: (2014-12-01)